Download PDF
Semin Respir Crit Care Med 2003; 24(6): 727-736
DOI: 10.1055/s-2004-815668
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Airway Clearance Techniques

Patrick A. Flume
  • Pediatrics and Medicine, Medical University of South Carolina, Charleston, South Carolina
Further Information

Publication History

Publication Date:
15 January 2004 (online)

    Permissions and Reprints

ABSTRACT

The airways of the patient with cystic fibrosis (CF) are chronically infected. There is excess mucus within the airways and, because of the chronic infection, the mucus also contains bacteria and inflammatory cells. Mucociliary clearance is impaired in patients with CF, and patients become dependent upon cough and other techniques to clear their airways of the thick sputum. This review discusses the various techniques and medications that have been demonstrated to be effective at assisting the clearance of the excess secretions in the CF airways. No single method has been proven to be better than the others, and not all patients will benefit, or use, the same techniques. Therefore, the methods of airway clearance must be tailored for each patient to assure effective therapy.

KEYWORDS

Cystic fibrosis - airway clearance - mucociliary clearance

REFERENCES

  • 1 King M, Rubin B K. Rheology of airway mucus: relationship with clearance function. In: Takashima T, Shimura S, eds. Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion New York: Marcel Dekker 1994: 283-314
    Google Scholar
  • 2 Regnis J A, Robinson M, Bailey D L. et al . Mucociliary clearance in patients with cystic fibrosis and in normal subjects.  Am J Respir Crit Care Med . 1994;  150 66-71
    PubMedGoogle Scholar
  • 3 Pfleger A, Theissl B, Oberwaldner B. et al . Self-administered chest physiotherapy in cystic fibrosis: a comparative study of high-pressure PEP and autogenic drainage.  Lung . 1992;  170 323-330
    PubMedGoogle Scholar
  • 4 Miller S, Hall D O, Clayton C B. et al . Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage.  Thorax . 1995;  50 165-169
    CrossrefPubMedGoogle Scholar
  • 5 Button B M, Heine R G, Catto-Smith A G. et al . Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis.  Arch Dis Child . 1997;  76 148-150
    CrossrefPubMedGoogle Scholar
  • 6 Button B M, Heine R G, Catto-Smith A G. et al . Postural drainage in cystic fibrosis: is there a link with gastro-oesophageal reflux?.  J Paediatr Child Health . 1998;  34 330-334
    PubMedGoogle Scholar
  • 7 Vandenplas Y, Diericx A, Blecker U. et al . Esophageal pH monitoring data during chest physiotherapy.  J Pediatr Gastroenterol Nutr . 1991;  13 23-26
    CrossrefPubMedGoogle Scholar
  • 8 Orenstein S R. Respiratory complications of reflux disease in infants. In: Stein MR, ed. Gastroesophageal Reflux Disease and Airway Disease New York: Marcel Dekker, 1999: 269-284
    Google Scholar
  • 8a AARC Clinical Practice Guideline. Use of positive airway pressure adjuncts to bronchial hygiene therapy. American Association for Respiratory Care.  Respir Care . 1993;  38 516-521
    PubMedGoogle Scholar
  • 8b AARC Clinical Practice Guideline. Directed cough. American Association for Respiratory Care.  Respir Care . 1993;  38 495-499
    PubMedGoogle Scholar
  • 8c AARC Clinical Practice Guideline. Postural drainage therapy. American Association for Respiratory Care.  Respir Care . 1991;  36 1418-1426
    PubMedGoogle Scholar
  • 9 Partridge C, Pryor J, Webber B. Characteristics of the forced expiratory technique.  Physiotherapy . 1989;  75 193-194
    PubMedGoogle Scholar
  • 10 Hardy K A. A review of airway clearance: new techniques, indications, and recommendations.  Respir Care . 1994;  39 440-455
    PubMedGoogle Scholar
  • 11 Pryor J A, Webber B A. An evaluation of the forced expiration technique as an adjunct to postural drainage.  Physiotherapy . 1979;  65 304-307
    PubMedGoogle Scholar
  • 12 Pryor J A. The forced expiratory technique. In: Pryor J, ed. International Perspectives in Physical Therapy-7 Respiratory Care. Edinburgh: Churchill Livingstone 1991: 79-100
    Google Scholar
  • 13 Chevaillier J. Autogenic drainage. In: Lawson D, ed. Cystic Fibrosis: Horizons Chichester: John Wiley 1984: 235
    Google Scholar
  • 14 Andersen J B, Qvist J, Kann T. Recruiting collapsed lung through collateral channels with positive end-expiratory pressure.  Scand J Respir Dis . 1979;  60 260-266
    PubMedGoogle Scholar
  • 15 Paul W L, Downs J B. Postoperative atelectasis: intermittent positive pressure breathing, incentive spirometry, and face-mask positive end-expiratory pressure.  Arch Surg . 1981;  116 861-863
    PubMedGoogle Scholar
  • 16 Andersen J B, Jespersen W. Demonstration of intersegmental respiratory bronchioles in normal human lungs.  Eur J Respir Dis . 1980;  61 337-341
    PubMedGoogle Scholar
  • 17 McIlwaine P M, Wong L T, Peacock D. et al . Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis.  J Pediatr . 1997;  131 570-574
    CrossrefPubMedGoogle Scholar
  • 18 Flume P A. Pneumothorax in cystic fibrosis.  Chest . 2003;  123 217-221
    CrossrefPubMedGoogle Scholar
  • 19 Zach M, Oberwaldner B. Effect of positive expiratory pressure breathing in patients with cystic fibrosis [letter to the editor].  Thorax . 1992;  47 66-67
    PubMedGoogle Scholar
  • 20 Konstan M W, Stern R C, Doershuk C F. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis.  J Pediatr . 1994;  124 689-693
    CrossrefPubMedGoogle Scholar
  • 21 Warwick W J, Hansen L G. The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis.  Pediatr Pulmonol . 1991;  11 265-271
    CrossrefPubMedGoogle Scholar
  • 22 Arens R, Gozal D, Omlin K J. et al . Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis.  Am J Respir Crit Care Med . 1994;  150 1154-1157
    PubMedGoogle Scholar
  • 23 Hansen L G, Warwick W J. High-frequency chest compression system to aid in clearance of mucus from the lung.  Biomed Instrum Technol . 1990;  24 289-294
    PubMedGoogle Scholar
  • 24 Oldenburg Jr A F, Dolovich M B, Montgomery J M. et al . Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis.  Am Rev Respir Dis . 1979;  120 739-745
    PubMedGoogle Scholar
  • 25 Zach M, Oberwaldner B, Hausler F. Cystic fibrosis: physical exercise versus chest physiotherapy.  Arch Dis Child . 1982;  57 587-589
    PubMedGoogle Scholar
  • 26 Edlund L D, French R W, Herbst J J. et al . Effects of a swimming program on children with cystic fibrosis.  Am J Dis Child . 1986;  140 80-83
    PubMedGoogle Scholar
  • 27 Bilton D, Dodd M E, Abbot J V. et al . The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis.  Respir Med . 1992;  86 507-511
    CrossrefPubMedGoogle Scholar
  • 28 Baldwin D R, Hill A L, Peckham D G. et al . Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis.  Respir Med . 1994;  88 49-53
    PubMedGoogle Scholar
  • 29 Salh W, Bilton D, Dodd M. et al . Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis.  Thorax . 1989;  44 1006-1008
    CrossrefPubMedGoogle Scholar
  • 30 Thomas J, Cook D J, Brooks D. Chest physical therapy management of patients with cystic fibrosis: a meta-analysis.  Am J Respir Crit Care Med . 1995;  151 846-850
    PubMedGoogle Scholar
  • 31 Prasad S A, Tannenbaum E L, Mikelsons C. Physiotherapy in cystic fibrosis.  J R Soc Med . 2000;  93 27-36
    PubMedGoogle Scholar
  • 32 Desmond K J, Schwenk W F, Thomas E. et al . Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis.  J Pediatr . 1983;  103 538-542
    PubMedGoogle Scholar
  • 33 Regelmann W E, Elliott G R, Warwick W J. et al . Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.  Am Rev Respir Dis . 1990;  141 914-921
    CrossrefPubMedGoogle Scholar
  • 34 Coates A L. Chest physiotherapy in cystic fibrosis: spare the hand and spoil the cough?.  J Pediatr . 1997;  131 506-508
    PubMedGoogle Scholar
  • 35 Rubin B K. The pharmacologic approach to airway clearance: mucoactive agents.  Respir Care . 2002;  47 818-822
    PubMedGoogle Scholar
  • 36 Reas H W. The effect of N-acetylcysteine on the viscosity of tracheobronchial secretions.  J Pediatr . 1963;  62 31-35
    PubMedGoogle Scholar
  • 37 Denton R, Kwart H, Litt M. N-acetylcysteine in cystic fibrosis: mechanical and chemical factors in treatment by aerosol.  Am Rev Respir Dis . 1967;  95 643-651
    PubMedGoogle Scholar
  • 38 Duijvestijn Y C, Brand P L. Systematic review of N-acetylcysteine in cystic fibrosis.  Acta Paediatr . 1999;  88 38-41
    CrossrefPubMedGoogle Scholar
  • 39 Howatt W F, DeMuth G R. A double-blind study of the use of acetylcysteine in patients with cystic fibrosis.  Univ Mich Med Cent J . 1966;  32 82-85
    PubMedGoogle Scholar
  • 40 Tecklin J S, Holsclaw Jr S D. Bronchial drainage with aerosol medications in cystic fibrosis.  Phys Ther . 1976;  56 999-1003
    PubMedGoogle Scholar
  • 41 Dano G. Bronchospasm caused by acetylcysteine in children with bronchial asthma.  Acta Allergol . 1971;  26 181-190
    PubMedGoogle Scholar
  • 42 Picot R, Das I, Reid L. Pus, deoxyribonucleic acid, and sputum viscosity.  Thorax . 1978;  33 235-242
    PubMedGoogle Scholar
  • 43 Smith A L, Redding G, Doershuk C. et al . Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis.  J Pediatr . 1988;  112 547-554
    CrossrefPubMedGoogle Scholar
  • 44 Lethem M I, James S L, Marriott C. et al . The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum.  Eur Respir J . 1990;  3 19-23
    PubMedGoogle Scholar
  • 45 Shak S. Aerosolized recombinant human DNase 1 for the treatment of cystic fibrosis.  Chest . 1995;  107 S65-S70
    PubMedGoogle Scholar
  • 46 Ramsey B W, Astley S J, Aitken M L. et al . Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.  Am Rev Respir Dis . 1993;  148 145-151
    PubMedGoogle Scholar
  • 47 Fuchs H J, Borowitz D S, Christiansen D H. et al . Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.  N Engl J Med . 1994;  331 637-642
    CrossrefPubMedGoogle Scholar
  • 48 McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.  Chest . 1996;  110 889-895
    CrossrefPubMedGoogle Scholar
  • 49 Robinson M, Regnis J A, Bailey D L. et al . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.  Am J Respir Crit Care Med . 1996;  153 1503-1509
    PubMedGoogle Scholar
  • 50 Eng P A, Morton J, Douglass J A. et al . Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.  Pediatr Pulmonol . 1996;  21 77-83
    CrossrefPubMedGoogle Scholar
  • 51 King M, Dasgupta B, Tomkiewicz R P. et al . Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.  Am J Respir Crit Care Med . 1997;  156 173-177
    CrossrefPubMedGoogle Scholar
  • 52 Bennett W D. Effect of beta-adrenergic agonists on mucociliary clearance.  J Allerg Clin Immunol . 2002;  110 (suppl 6) S291-S297
    CrossrefPubMedGoogle Scholar
  • 53 Sanderson M J, Dirksen E R. Mechanosensitive and beta-adrenergic control of the ciliary beat frequency of mammalian respiratory tract cells in culture.  Am Rev Respir Dis . 1989;  139 432-440
    PubMedGoogle Scholar
  • 54 Verdugo P, Johnson N T, Tam P Y. Beta-adrenergic stimulation of respiratory ciliary activity.  J Appl Physiol Respir Environ Exerc Physiol . 1980;  48 868-871
    PubMedGoogle Scholar
  • 55 Wanner A, Salathe M, O'Riordan T G. Mucociliary clearance in the airways.  Am J Respir Crit Care Med . 1996;  154 1868-1902
    PubMedGoogle Scholar
  • 56 Sturgess J, Reid L. An organ culture study of the effect of drugs on the secretory activity of the human bronchial submucosal gland.  Clin Sci . 1972;  43 533-543
    PubMedGoogle Scholar
  • 57 Shelhamer J H, Marom Z, Kaliner M. Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro.  J Clin Invest . 1980;  66 1400-1408
    PubMedGoogle Scholar
  • 58 Phipps R J, Nadel J A, Davis B. Effect of alpha-adrenergic stimulation on mucus secretion and on ion transport in cat trachea in vitro.  Am Rev Respir Dis . 1980;  121 359-365
    PubMedGoogle Scholar
  • 59 Webber S E, Widdicombe J G. The actions of methacholine, phenylephrine, salbutamol and histamine on mucus secretion from the ferret in-vitro trachea.  Agents Actions . 1987;  22 82-85
    PubMedGoogle Scholar
  • 60 Jones R, Reid L. Beta-agonists and secretory cell number and intracellular glycoproteins in airway epitheliumz: the effect of isoproterenol and salbutamol.  Am J Pathol . 1979;  95 407-421
    PubMedGoogle Scholar
  • 61 Widdicombe J H, Bastacky S J, Wu D X. et al . Regulation of depth and composition of airway surface liquid.  Eur Respir J . 1997;  10 2892-2897
    CrossrefPubMedGoogle Scholar
  • 62 Davis B, Marin M G, Yee J W. et al . Effect of terbutaline on movement of Cl- and Na+ across the trachea of the dog in vitro.  Am Rev Respir Dis . 1979;  120 547-552
    PubMedGoogle Scholar
  • 63 Yeates D B, Aspin N, Levison H. et al . Mucociliary tracheal transport rates in man.  J Appl Physiol . 1975;  39 487-495
    PubMedGoogle Scholar
  • 64 Houtmeyers E, Gosselink R, Gayan-Ramirez G. et al . Effects of drugs on mucus clearance.  Eur Respir J . 1999;  14 452-467
    PubMedGoogle Scholar
  • 65 Mossberg B, Strandberg K, Philipson K. et al . Tracheobronchial clearance in bronchial asthma: response to beta-adrenoceptor stimulation.  Scand J Respir Dis . 1976;  57 119-128
    PubMedGoogle Scholar
  • 66 Wood R E, Wanner A, Hirsch J. et al . Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline.  Am Rev Respir Dis . 1975;  111 733-738
    PubMedGoogle Scholar
  • 67 Mortensen J, Hansen A, Falk M. et al . Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.  Chest . 1993;  103 805-811
    PubMedGoogle Scholar
  • 68 Avital A, Sanchez I, Chernick V. Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis.  Pediatr Pulmonol . 1992;  13 34-37
    PubMedGoogle Scholar
      >